Selecta Biosciences Inc. (SELB)
NASDAQ: SELB
· Real-Time Price · USD
0.88
-0.08 (-8.12%)
At close: Nov 13, 2023, 10:00 PM
Selecta Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -99.86M | -91.16M | -67.17M | -36.16M | -35.05M | -15.06M | 35.38M | 41.73M | 31.72M | 27.69M | -25.69M | -53.37M | -45.21M | -73.85M |
Depreciation & Amortization | 2.04M | 1.07M | 665K | 812K | 973K | 1.14M | 1.29M | 1.45M | 1.44M | 1.4M | 1.25M | 1.09M | 890K | 710K |
Stock-Based Compensation | -677K | -864K | 4.72M | 10.66M | 10.94M | 10.72M | 11.19M | 11.17M | 10.47M | 8.69M | 7.72M | 6.7M | 6.09M | 5.79M |
Other Working Capital | -1.84M | -2.81M | n/a | -4M | -17.44M | -32.11M | -64.1M | -90.54M | -73.71M | -66.2M | -45.28M | -17.33M | 71.41M | 82.2M |
Other Non-Cash Items | 84.19M | 84.55M | 45.12M | -7.48M | -1.22M | -1.28M | -5.42M | -680K | -7.4M | -12.22M | 4.53M | 20.31M | 16.57M | 28.68M |
Deferred Income Tax | 19.06M | 16.02M | n/a | -9.39M | -6.02M | 4.97M | -13.69M | -22.67M | -23.57M | -33.03M | 2.4M | 18.2M | 14.46M | 26.77M |
Change in Working Capital | -12.16M | -12.19M | n/a | 1.84M | 4.22M | -29.01M | -60.38M | -91.21M | -88.56M | -67.01M | -48.19M | -10.91M | 61.86M | 73.11M |
Operating Cash Flow | -16.47M | -2.58M | -16.67M | -39.72M | -26.16M | -28.53M | -31.63M | -51.24M | -66.34M | -60.11M | -60.38M | -36.17M | 40.21M | 34.45M |
Capital Expenditures | -18.4M | -17.33M | -8.39M | -353K | -789K | -876K | -1.2M | -1.27M | -996K | -1.51M | -1.08M | -997K | -1.12M | -705K |
Cash Acquisitions | n/a | n/a | n/a | n/a | 29.5M | 29.5M | 29.5M | 29.5M | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | -33.5M | -33.5M | -33.5M | -33.5M | -8.04M | -10.04M | -32.45M | -32.45M | -24.42M | -22.42M |
Sales Maturities Of Investments | -28.25M | -28.25M | n/a | 33.95M | 37.95M | 37.95M | 19.7M | 24M | 20M | 20M | 10M | n/a | n/a | n/a |
Other Investing Acitivies | 351K | 351K | n/a | n/a | -29.5M | -29.5M | -29.5M | -29.5M | 6.4M | 6.4M | 6.4M | 6.42M | 29K | 74K |
Investing Cash Flow | -46.3M | -45.23M | -8.39M | 33.6M | 3.66M | 3.58M | -15M | -10.77M | 17.37M | 14.85M | -17.14M | -27.03M | -25.51M | -23.05M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -149K | -149K | n/a | 149K | 149K | 149K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 352.54M | 335.78M | 152.52M | -27.23M | -1.82M | 37.64M | 39.22M | 60.37M | 61.21M | 33.32M | 52.9M | 31.55M | 51.05M | 41.11M |
Financial Cash Flow | 382.65M | 365.88M | 167.65M | -27.23M | -1.82M | 37.64M | 39.22M | 60.37M | 61.21M | 33.32M | 52.9M | 31.55M | 51.05M | 41.11M |
Net Cash Flow | 241.01M | 239.16M | 93.34M | -33.46M | -24.43M | 12.71M | -7.4M | -1.58M | 12.31M | -11.97M | -24.63M | -31.62M | 65.74M | 52.52M |
Free Cash Flow | -34.87M | -19.9M | -25.06M | -40.08M | -26.95M | -29.41M | -32.83M | -52.51M | -67.34M | -61.63M | -61.47M | -37.17M | 39.09M | 33.74M |